review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1007/S11095-006-9091-5 |
P698 | PubMed publication ID | 17048121 |
P2093 | author name string | Reynold Spector | |
Conrad Johanson | |||
P2860 | cites work | Molecular identification of a renal urate anion exchanger that regulates blood urate levels | Q24297979 |
Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion | Q24303038 | ||
Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke | Q24555180 | ||
Active transport properties of porcine choroid plexus cells in culture | Q47985590 | ||
Effects of myo-inositol ingestion on human brain myo-inositol levels: a proton magnetic resonance spectroscopic imaging study | Q48208731 | ||
Inositol accumulation by brain slices in vitro | Q48351227 | ||
The specificity and sulfhydryl sensitivity of the inositol transport system of the central nervous system | Q48378427 | ||
The origin of myo‐inositol in brain, cerebrospinal fluid and choroid plexus | Q48443341 | ||
Folate transport by the choroid plexus in vitro | Q48476074 | ||
Rapid and transient up-regulation of Na+/myo-inositol cotransporter transcription in the brain of acute hypernatremic rats | Q48952743 | ||
Myo-inositol transport through the blood-brain barrier. | Q55060546 | ||
The mammalian choroid plexus | Q60153480 | ||
Active transport of riboflavin by the isolated choroid plexus in vitro | Q66943251 | ||
Development of the vitamin transport systems in choroid plexus and brain | Q67007414 | ||
Cerebral folate deficiency | Q67224945 | ||
Riboflavin transport by rabbit kidney slices: characterization and relation to cyclic organic acid transport | Q70349580 | ||
Lumiflavin and lumichrome transport in the central nervous system | Q70690722 | ||
Riboflavin accumulation by rabbit brain slices in vitro | Q71214989 | ||
Riboflavin homeostasis in the central nervous system | Q71442334 | ||
Penetration of ascorbic acid from cerebrospinal fluid into brain | Q71552439 | ||
Cellular localization of Na+/MYO-inositol co-transporter mRNA in the rat brain | Q71558854 | ||
A family of mammalian Na+-dependent L-ascorbic acid transporters | Q28144223 | ||
Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters | Q28379253 | ||
Sodium/myo-inositol cotransporter-1 is essential for the development and function of the peripheral nerves | Q28507730 | ||
Loss of murine Na+/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea | Q28585058 | ||
Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival | Q28587083 | ||
Phosphoinositide deficiency due to inositol depletion is not a mechanism of lithium action in brain | Q33202339 | ||
Drug transport in the mammalian central nervous system: multiple complex systems. A critical analysis and commentary | Q33829184 | ||
Ascorbate regulation and its neuroprotective role in the brain | Q33899469 | ||
Autoantibodies to folate receptors in the cerebral folate deficiency syndrome. | Q34418174 | ||
Inhibition of Penicillin Transport from the Cerebrospinal Fluid after Intracisternal Inoculation of Bacteria | Q34464786 | ||
Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance | Q34928951 | ||
A review of folate receptor alpha cycling and 5-methyltetrahydrofolate accumulation with an emphasis on cell models in vitro | Q35749867 | ||
Peptide and peptide analog transport systems at the blood-CSF barrier. | Q35894195 | ||
Confocal imaging of xenobiotic transport across the choroid plexus | Q35894201 | ||
Usefulness and limitation of primary cultured porcine choroid plexus epithelial cells as an in vitro model to study drug transport at the blood-CSF barrier | Q35894209 | ||
Expression systems for cloned xenobiotic transporters | Q36104166 | ||
Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route | Q36199725 | ||
The influx of ascorbic acid into the rat's brain | Q36479653 | ||
Riboflavin transport in the central nervous system. Characterization and effects of drugs | Q37027671 | ||
Micronutrient homeostasis in mammalian brain and cerebrospinal fluid | Q38713141 | ||
Vitamin Homeostasis in the Central Nervous System | Q39621685 | ||
On the active transport of organic acids (fluorescein) in the choroid plexus of the rabbit | Q40202725 | ||
Vitamin C uptake and recycling among normal and tumor cells from the central nervous system | Q40485048 | ||
Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development | Q40925359 | ||
Inositol monophosphatase inhibitors--lithium mimetics? | Q41370417 | ||
Blood-brain barrier transport of reduced folic acid | Q41647539 | ||
Localization of the murine reduced folate carrier as assessed by immunohistochemical analysis | Q43654182 | ||
Confocal imaging of organic anion transport in intact rat choroid plexus | Q43948744 | ||
Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus | Q43964692 | ||
Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. | Q43993855 | ||
Identification of a novel Na+/myo-inositol cotransporter | Q44074174 | ||
Specificity of ascorbic acid transport system of the central nervous system | Q44093962 | ||
Contribution of organic anion transporter 3 (Slc22a8) to the elimination of p-aminohippuric acid and benzylpenicillin across the blood-brain barrier | Q44396321 | ||
Reduced folate transport to the CNS in female Rett patients | Q44562258 | ||
Mechanisms of cefadroxil uptake in the choroid plexus: studies in wild-type and PEPT2 knockout mice | Q44644016 | ||
Myo-inositol transport in the central nervous system | Q44780606 | ||
Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice | Q44838084 | ||
Sodium vitamin C cotransporter SVCT2 is expressed in hypothalamic glial cells | Q45206753 | ||
Maternal folate deficiency results in selective upregulation of folate receptors and heterogeneous nuclear ribonucleoprotein-E1 associated with multiple subtle aberrations in fetal tissues | Q45217529 | ||
Folate transport in the central nervous system | Q45431922 | ||
Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter | Q46661459 | ||
Purification and characterization of a folate binding protein from porcine choroid plexus | Q46824511 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2515-2524 | |
P577 | publication date | 2006-10-18 | |
P1433 | published in | Pharmaceutical Research | Q7180737 |
P1476 | title | Micronutrient and urate transport in choroid plexus and kidney: implications for drug therapy | |
P478 | volume | 23 |
Q26801533 | A balanced view of the cerebrospinal fluid composition and functions: Focus on adult humans |
Q36503000 | A humanized mouse model for the reduced folate carrier |
Q34763623 | A milk-free diet downregulates folate receptor autoimmunity in cerebral folate deficiency syndrome |
Q36135976 | A molecular characterization of the choroid plexus and stress-induced gene regulation |
Q88808744 | Altered folate binding protein expression and folate delivery are associated with congenital hydrocephalus in the hydrocephalic Texas rat |
Q37172100 | Ascorbic acid and rates of cognitive decline in Alzheimer's disease. |
Q36889482 | Blood-cerebrospinal fluid barrier in hyperthermia. |
Q41949235 | Characterization of immortalized choroid plexus epithelial cell lines for studies of transport processes across the blood-cerebrospinal fluid barrier |
Q34355646 | Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma |
Q35596169 | Choroid plexus transport: gene deletion studies |
Q48269323 | Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis |
Q36186589 | Expression Profiling of Solute Carrier Gene Families at the Blood-CSF Barrier |
Q31000806 | Expression and analysis of two novel rat organic cation transporter homologs, SLC22A17 and SLC22A23. |
Q33799643 | Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study |
Q40036018 | Intracerebroventricularly administered neurotrophins attenuate blood cerebrospinal fluid barrier breakdown and brain pathology following whole-body hyperthermia: an experimental study in the rat using biochemical and morphological approaches |
Q28235219 | KCNQ1, KCNE2, and Na+-coupled solute transporters form reciprocally regulating complexes that affect neuronal excitability |
Q37274442 | Molecular mechanisms of adaptation to folate deficiency |
Q37163564 | Multiplicity of cerebrospinal fluid functions: New challenges in health and disease |
Q37712631 | Non-Neuronal Cells in the Hypothalamic Adaptation to Metabolic Signals |
Q35910783 | Noninvasive quantification of human brain antioxidant concentrations after an intravenous bolus of vitamin C. |
Q33800053 | Nrf2 signaling contributes to the neuroprotective effects of urate against 6-OHDA toxicity |
Q37075336 | Oligomeric structure of the human reduced folate carrier: identification of homo-oligomers and dominant-negative effects on carrier expression and function |
Q30443495 | Positive modulation of the α9α10 nicotinic cholinergic receptor by ascorbic acid |
Q36586281 | Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease |
Q33913246 | Selenoprotein P and apolipoprotein E receptor-2 interact at the blood-brain barrier and also within the brain to maintain an essential selenium pool that protects against neurodegeneration |
Q34657202 | Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter |
Q34162009 | Substrate-specific binding and conformational changes involving Ser313 and transmembrane domain 8 of the human reduced folate carrier, as determined by site-directed mutagenesis and protein cross-linking |
Q33788462 | Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system |
Q33748671 | Targeting the choroid plexus-CSF-brain nexus using peptides identified by phage display |
Q37810006 | The Blood–Cerebrospinal Fluid Barrier: Structure and Functional Significance |
Q37824369 | The distributional nexus of choroid plexus to cerebrospinal fluid, ependyma and brain: toxicologic/pathologic phenomena, periventricular destabilization, and lesion spread. |
Q38177375 | The nexus of vitamin homeostasis and DNA synthesis and modification in mammalian brain. |
Q36764538 | The origin of deoxynucleosides in brain: implications for the study of neurogenesis and stem cell therapy. |
Q24682055 | The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption |